NCT03786081 2026-03-13
Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer
Seagen Inc.
Phase 1/2 Active not recruiting
Clinical Trials
7 trialsNCT04644068 2026-02-19
PETRA
AstraZeneca
Phase 1/2 Active not recruiting
NCT04982237 2025-11-19
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
Akeso
Phase 3 Active not recruiting
NCT01566240 2024-12-05
INTERLACE
University College, London
Phase 3 Active not recruiting
NCT04723875 2024-11-01
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
Huazhong University of Science and Technology
Phase 3 Active not recruiting
NCT04652076 2024-10-08
GYNET
NETRIS Pharma
Phase 1/2 Active not recruiting
NCT06419673 2024-05-17
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting